Angioimmunoblastic T-Cell Lymphoma after Treatment of Classic Hodgkin Lymphoma: A Case Report

Bibliographic Details
Title: Angioimmunoblastic T-Cell Lymphoma after Treatment of Classic Hodgkin Lymphoma: A Case Report
Authors: Ken Tanaka, Hiroaki Miyoshi, Yusuke Yamashita, Ryuta Iwamoto, Yuma Yokoya, Yuichi Tochino, Fumiko Arakawa, Shinobu Tamura, Shin-Ichi Murata, Takashi Sonoki, Koichi Ohshima
Source: Hematology Reports, Vol 15, Iss 4, Pp 662-669 (2023)
Publisher Information: MDPI AG, 2023.
Publication Year: 2023
Collection: LCC:Diseases of the blood and blood-forming organs
Subject Terms: classic hodgkin lymphoma, lymphocyte rich classic hodgkin lymphoma, angioimmunoblastic T-cell lymphoma, secondary non-hodgkin lymphoma, Diseases of the blood and blood-forming organs, RC633-647.5
More Details: We report a case of a 24-year-old man who developed angioimmunoblastic T-cell lymphoma (AITL) after treatment for refractory lymphocyte-rich classic Hodgkin lymphoma (LR-CHL). This patient was treated with the BV+AVD (brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine) protocol for LR-CHL but progressed before completing chemotherapy. The pathological imaging showed the typical findings of LR-CHL at the first onset and first progression. Rescue chemotherapy and high-dose chemotherapy combined with autologous hematopoietic stem cell transplantation (AHSCT) were performed for refractory LR-CHL, and complete remission was achieved. However, the recurrence was suspected 6 months after AHSCT. The pathological findings of the lymph node biopsy at this time were different from those of the previous two lymph node biopsies, demonstrating findings of AITL. The finding of the immunohistochemical staining and polymerase chain reaction results supported the diagnosis. Although it has been reported that the risk for the development of non-Hodgkin lymphoma after treatment for Hodgkin lymphoma is increased, most are B-cell lymphomas, and few cases of AITL have been reported. AITL is a type of peripheral T-cell lymphoma that generally occurs in middle-aged and elderly people and that rarely occurs in young people. Here, we were able to make an accurate diagnosis by performing re-examination even when recurrence of LR-CHL was suspected. As there are no detailed case reports of AITL developing into secondary non-Hodgkin lymphoma, here we report on an identified case.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2038-8330
Relation: https://www.mdpi.com/2038-8330/15/4/67; https://doaj.org/toc/2038-8330
DOI: 10.3390/hematolrep15040067
Access URL: https://doaj.org/article/4012cc9982094fbcac92fe7a8036bffe
Accession Number: edsdoj.4012cc9982094fbcac92fe7a8036bffe
Database: Directory of Open Access Journals
More Details
ISSN:20388330
DOI:10.3390/hematolrep15040067
Published in:Hematology Reports
Language:English